European Immuno-Oncology Collaboration

European Immuno-Oncology Collaboration

As reported in Associated Press, the National Center for Tumor Diseases (NCT) and NEC Laboratories Europe GmbH have announced a collaboration to improve the in silico prediction of immunotherapy response in malignant melanoma. Cancer immunotherapy, e.g. by Checkpoint...

Pin It on Pinterest